Sero-prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) specific antibodies in dromedary camels in Tabuk, Saudi Arabia

Journal of Medical Virology

Volumn 90, Issue 8, 2018, Pages 1285-1289

  Harrath, Rafik ^a,b   Abu Duhier, Faisel M ^a  

^a UNIVERSITY OF TABUK   (Saudi Arabia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

blood; Coronavirus; enzyme assays; immunoglobulin; reservoir

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; CORONAVIRUS SPIKE GLYCOPROTEIN; IMMUNOGLOBULIN G;

ADULT; AGE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DROMEDARY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; JUVENILE ANIMAL; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; SAUDI ARABIA; SEROPREVALENCE; ANIMAL; BLOOD; CAMEL; CORONAVIRUS INFECTION; IMMUNOLOGY; SEROEPIDEMIOLOGY; VETERINARY MEDICINE;

ANIMALS; ANTIBODIES, VIRAL; CAMELUS; CORONAVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SAUDI ARABIA; SEROEPIDEMIOLOGIC STUDIES; SPIKE GLYCOPROTEIN, CORONAVIRUS;

EID: 85046016303     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.25186     Document Type: Article

References (25)

1. Saudi Ministry of Health (MOH). Middle East respiratory syndrome coronavirus (MERS-CoV) update. November 6, 2017. https://www.moh.gov.sa
2. Bermingham A, Chand MA, Brown CS, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012; 17:pii=20290.
3. World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update. July 9, 2013. Geneva: WHO. [Accessed 20 Aug 2013].
4. Annan A, Baldwin HJ, Corman VM, et al. Human betacoronavirus 2c EMC/2012- related viruses in bats, Ghana and Europe. Emerg Infect Dis. 2013; 19:456–459.
5. Ithete NL, Stoffberg S, Corman VM, et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis. 2013; 19:1697–1699.
6. Memish ZA, Mishra N, Olival KJ, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis. 2013; 19:1819–1823.
7. Alagaili AN, Briese T, Mishra N, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio. 2014; 5:e01002–e01004.
8. Cotten M, Watson SJ, Kellam P, et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet. 2013; 382:1993–2002.
9. Nowotny N, Kolodziejek J. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill. 2014; 19:pii: 20781.
10. Haagmans BL, Al Dhahiry SH, Reusken CB, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 2014; 14:140–145.
11. Memish ZA, Cotten M, Meyer B, et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis. 2014; 20:1012–1015.
12. Reusken CB, Haagmans BL, Muller MA, et al. Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013; 13:859–866.
13. Cao WC, Liu W, Zhang PH, Zhang F, Richardus JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007; 357:1162–1163.
14. Corman VM, Muller MA, Costabel U, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012; 17:20334.
15. Reusken C, Mou H, Godeke GJ, et al. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill. 2013; 18:20441.
16. Müller MA, Corman VM, Jores J, et al. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983–1997. Emerg Infect Dis 2014; 20:2093–2095.
17. Corman VM, Jores J, Meyer B, et al. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013. Emerg Infect Dis. 2014; 20:1319–1322.
18. Meyer B, Müller MA, Corman VM, et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis. 2014; 20:552–559.
19. Perera RA, Wang P, Gomaa M, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013; 18:20574.
20. Reusken CB, Messadi L, Feyisa A, et al. Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis. 2014; 20:1370–1374.
21. Crameri G, Durr P, Barr J, et al. Absence of MERS-CoV antibodies in feral camels in Australia: implications for the pathogen's origin and spread. One Health. 2015; 1:76–82.
22. Gutiérrez C, Tejedor-Junco MT, González M, Lattwein E, Renneker S. Presence of antibodies but no evidence for circulation of MERS-CoV in dromedaries on the Canary Islands. Euro Surveill. 2015; 20.
23. Benjamin M, Judit J, Rajib B, et al. Time course of MERS-CoV infection and immunity in dromedary camels. Emerg Infect Dis. 2016; 22:2171–2173.
24. Hemida MG, Perera RA, Wang P, et al. Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill. 2013; 18:20659.
25. Kamber R, Farah Z, Rusch P, Hassig M. Studies on the supply of immunoglobulin G to newborn camel calves (Camelus dromedarius). J Dairy Res. 2001; 68:1–7.